Researchers found a gene variant linked to a blood protein level and to MS in health records.
Researchers measured about 3,000 blood proteins in Black adults. They found about 1,000 links between gene variants and blood protein levels. They checked their findings in another study and searched health records for links to diseases. One gene variant was linked to a blood protein level, white blood cell count, and MS. Other variants were linked to sarcoidosis and non-Hodgkin's lymphoma.
The first part of the study included Black adults, not just people with MS. Researchers also used another study and health records from groups with varied backgrounds. Most earlier studies of this kind focused on White people with European ancestry. The MS finding was one part of a wider study of gene variants, blood proteins, and diseases. It may interest people with MS, but the abstract does not say how many participants had MS.
You should know that the first study included 1,054 Black adults; the abstract does not give a total for the other groups. You should know this study looked for links, so it cannot show that the gene variant causes MS. You should know the abstract does not describe a new MS test or treatment.
AI-generated summary — for informational purposes only, not medical advice
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More11/1/2026
In a study of 294 pregnancies, MS flare-ups were uncommon after pausing two treatments. Learn what t
Read More10/9/2026
A mouse study suggests prepared red blood cells may calm MS-like immune attacks. Learn why liver cel
Read More10/9/2026
See how lab-grown nerve cells move a key protein, why this may matter for nerve health, and why the
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like The Journal of clinical investigation often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.